About 17,903 results

ALLMedicine™ Intraocular Pressure Center

Research & Reviews  6,090 results

Efficacy and Safety of the Preserflo Microshunt ® with Mytomicin C for the Treatment of...
Journal of Glaucoma; Ibarz Barberá M, Galdón FM et. al.

May 19th, 2022 - The PSM® is a safe and effective glaucoma micro-filtering implant that significantly reduces the intraocular pressure, either alone or in combination with phacoemulsification, during the first year after surgery. To assess the safety and efficacy ...

Host Immune Response and Associated Clinical Features in a Primary Cytomegalovirus Eye ...
Investigative Ophthalmology & Visual Science; Su CC, Gao CM et. al.

May 18th, 2022 - To investigate the pathogenesis of cytomegalovirus (CMV)-associated anterior segment infection in immunocompetent hosts and evaluate the effects of ganciclovir and glucocorticoid treatment in management of the disease. We used an inoculation model...

Intelligent wireless theranostic contact lens for electrical sensing and regulation of ...
https://doi.org/10.1038/s41467-022-29860-x 10.1126/sciadv.1601314 10.1126/sciadv.aba3252 10.1038/nnano.2016.38 10.1038/nnano.2014.38 10.1038/s41551-020-00604-w 10.1038/s41586-018-0823-6 10.1038/nrdp.2016.67 10.1016/S0140-6736(17)31469-1 10.1038/85446 10.1097/00061198-200306000-00009 10.1089/10807680260362687 10.1039/C8LC00758F 10.1038/clpt.2008.297 10.2165/11533180-000000000-00000 10.1002/adhm.201400504 10.3390/s18082651 10.1021/acs.nanolett.9b03605 10.1039/C9LC01268K 10.1126/sciadv.aap9841 10.1021/acsnano.7b07082 10.1167/tvst.9.4.1 10.1109/JMEMS.2019.2927232 10.1038/s41551-021-00719-8 10.1021/nn5002968 10.1002/adhm.201600775 10.1016/j.addr.2017.04.001 10.1002/adfm.201901474 10.1038/s41928-019-0304-4 10.1016/j.matt.2020.12.002 10.1126/sciadv.aay0764 10.1002/aisy.201900190 10.1038/s41551-018-0336-5 10.1016/j.sna.2013.08.029 10.1002/adma.201702800 10.1016/j.ejpb.2019.04.016 10.1126/science.1143254 10.1002/smll.201702479 10.1109/PROC.1984.12959 10.1038/s41551-021-00685-1 10.1208/s12248-010-9183-3 10.1002/adfm.201907378 10.1073/pnas.1701740114 10.1006/exer.2001.1098 10.1016/j.jconrel.2016.02.012
Nature Communications; Yang C, Wu Q et. al.

May 18th, 2022 - Engineering wearable devices that can wirelessly track intraocular pressure and offer feedback-medicine administrations are highly desirable for glaucoma treatments, yet remain challenging due to issues of limited sizes, wireless operations, and w...

see more →

Guidelines  2 results

Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema.
Ophthalmic Surgery, Lasers & Imaging Retina; Puliafito CA, Cousins SW et. al.

Apr 21st, 2016 - The diabetic macular edema (DME) treatment paradigm has evolved as the understanding of the disease pathology has grown. Since 2012, four pharmacotherapies have been approved by the U.S. Food and Drug Administration for the treatment of DME. First...

Screening for Glaucoma: Clinical Summary of USPSTF Recommendation

Jul 2nd, 2013 - SCREENING FOR GLAUCOMA CLINICAL SUMMARY OF U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION Population Adults without vision symptoms who are seen in primary care Recommendation No recommendation. Grade: I statement Ris...

see more →

Drugs  278 results see all →

Clinicaltrials.gov  396 results

Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure

May 12th, 2022 - This is a Phase 2, randomized, double-masked, placebo-controlled, parallel-group study in adult males and females, aged 18 years and over, with a diagnosis of glaucoma or ocular hypertension. This trial will be performed in 2 segments. In Segment ...

Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEX

May 12th, 2022 - Patients who were diagnosed as postoperative CME after uneventful intraocular surgery and administrated with intravitreal OZURDEX injection were reviewed. All patients underwent ophthalmic examinations at the initial visit and were followed up at ...

Study of LL-BMT1 in Patients With Elevated Intraocular Pressure

May 10th, 2022 - This is an open-label, Phase 2a clinical study of LL-BMT1 in patients with primary open-angle glaucoma and ocular hypertension. Study subjects will be treated for 7 days with a single dose of LL-BMT1.

Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry

May 10th, 2022 - While elevated intraocular pressure (IOP) is no longer part of the definition of glaucoma it remains the sole proven modifiable risk factor for the onset and progression of glaucoma. IOP is known to vary with the time of day as well as with daily ...

GATT Versus Canaloplasty (GVC)

May 9th, 2022 - Study aims to compare the effectiveness and safety profile of Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty, in order to find out if one operation is superior to the other. Both procedures are performed in patients with medically...

see more →

News  395 results

The PreserFlo Ab-Externo MicroShunt: A Conversation With Dr Ike Ahmed

May 19th, 2022 - Iqbal "Ike" K. Ahmed, MD, is a world-renowned ophthalmologist whose clinical work and research focus on glaucoma, complex cataracts, and intraocular lens complications. In 2020, The Ophthalmologist Power List named Dr Ahmed the second most influen...

Treatment of Keratopathy Associated with Belantamab Mafodotin

Mar 20th, 2022 - Sagar Lonial, MD, FACP: Dr Klugo, I want to come back to some of the belantamab [mafodotin]-associated keratopathy. You mentioned the KVA [Keratopathy and Visual Acuity] scale as a way to measure severity. Are there any data on how to treat belama...

Omidenepag Matches Latanoprost for Glaucoma

Nov 15th, 2021 - NEW ORLEANS, Louisiana — An experimental new drug for glaucoma and ocular hypertension is as effective as latanoprost but causes different adverse events, the results of a phase 3 clinical trial suggest. Approved in Japan in 2018 and under review ...

Cataract Surgery Alone or With the Hydrus Microstent?

Nov 9th, 2021 - Study Summary The HORIZON trial, which compared cataract surgery alone with cataract surgery in conjunction with implantation of the Hydrus Microstent (Ivantis, Inc; Irvine, California), concluded at 3 years that the combination surgery was more e...

NSAIDs Match Steroids for Cataract Surgery Inflammation

Aug 19th, 2021 - Nonsteroidal anti-inflammatory drugs (NSAIDs) given as eye drops appear to work as well alone as they do in combination with steroids to prevent swelling of the macula after cataract surgery, researchers say. The anti-inflammatory eye drops worked...

see more →